[1]
|
Germain, D.P. (2010) Fabry Disease. Orphanet Journal of Rare Diseases, 5, 30. https://doi.org/10.1186/1750-1172-5-30
|
[2]
|
Tsutsumi, O., Sato, M., Sato, K., Mizuno, M. and Sakamoto, S. (1985) Early Prenatal Diagnosis of Inborn Error of Metabolism: A Case Report of a Fetus Affected with Fabry’s Disease. Asia-Oceania Journal of Obstetrics and Gynaecology, 11, 39-45. https://doi.org/10.1111/j.1447-0756.1985.tb00045.x
|
[3]
|
Hopkin, R.J., Bissler, J., Banikazemi, M., Clarke, L., Eng, C.M., Germain, D.P., Lemay, R., Tylki-Szymanska, A. and Wilcox, W.R. (2008) Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry. Pediatric Research, 64, 550-555. https://doi.org/10.1203/PDR.0b013e318183f132
|
[4]
|
Waldek, S., Patel, M.R., Banikazemi, M., Lemay, R. and Lee, P. (2009) Life Expectancy and Cause of Death in Males and Females with Fabry Disease: Findings from the Fabry Registry. Genetics in Medicine, 11, 790-796. https://doi.org/10.1097/GIM.0b013e3181bb05bb
|
[5]
|
Najafian, B., Mauer, M., Hopkin, R.J. and Svarstad, E. (2013) Renal Complications of Fabry Disease in Children. Pediatric Nephrology, 28, 679-687. https://doi.org/10.1007/s00467-012-2222-9
|
[6]
|
Sheth, K.J., Roth, D.A. and Adams, M.B. (1983) Early Renal Failure in Fabry’s Disease. American Journal of Kidney Diseases, 2, 651-654. https://doi.org/10.1016/S0272-6386(83)80047-X
|
[7]
|
Tondel, C., Bostad, L., Hirth, A. and Svarstad, E. (2008) Renal Biopsy Findings in Children and Adolescents with Fabry Disease and Minimal Albuminuria. American Journal of Kidney Diseases, 51, 767-776. https://doi.org/10.1053/j.ajkd.2007.12.032
|
[8]
|
Fogo, A.B., Bostad, L., Svarstad, E., Cook, W.J., Moll, S., Barbey, F., Geldenhuys, L., West, M., Ferluga, D., Vujkovac, B., Howie, A.J., Burns, A., Reeve, R., Waldek, S., Noel, L.H., Grunfeld, J.P., Valbuena, C., Oliveira, J.P., Muller, J., Breunig, F., Zhang, X., Warnock, D.G. and All Members of the International Study Group of Fabry (2010) Scoring System for Renal Pathology in Fabry Disease: Report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrology Dialysis Transplantation, 25, 2168-2177. https://doi.org/10.1093/ndt/gfp528
|
[9]
|
Perretta, F., Antongiovanni, N. and Jaurretche, S. (2017) Early Renal Involvement in a Girl with Classic Fabry Disease. Case Reports in Nephrology, 2017, Article ID: 9543079. https://doi.org/10.1155/2017/9543079
|
[10]
|
Trimarchi, H., Canzonieri, R., Schiel, A., Costales-Collaguazo, C., Politei, J., Stern, A., Paulero, M., Rengel, T., Andrews, J., Forrester, M., Lombi, M., Pomeranz, V., Iriarte, R., Muryan, A., Zotta, E., Sanchez-Nino, M.D. and Ortiz, A. (2016) Increased Urinary CD80 Excretion and Podocyturia in Fabry Disease. Journal of Translational Medicine, 14, 289.
|
[11]
|
Trimarchi, H., Canzonieri, R., Schiel, A., Politei, J., Stern, A., Andrews, J., Paulero, M., Rengel, T., Araoz, A., Forrester, M., Lombi, F., Pomeranz, V., Iriarte, R., Young, P., Muryan, A. and Zotta, E. (2016) Podocyturia Is Significantly Elevated in Untreated vs Treated Fabryadult Patients. Journal of Nephrology, 29, 791-797. https://doi.org/10.1007/s40620-016-0271-z
|
[12]
|
Aguiar, P., Azevedo, O., Pinto, R., Marino, J., Baker, R., Cardoso, C., Ducla Soares, J.L. and Hughes, D. (2017) New Biomarkers Defining a Novel Early stage of Fabry Nephropathy: A Diagnostic Test Study. Molecular Genetics and Metabolism, 121, 162-169. https://doi.org/10.1016/j.ymgme.2017.05.007
|
[13]
|
Trionfini, P., Benigni, A. and Remuzzi, G. (2015) MicroRNAs in Kidney Physiology and Disease. Nature Reviews Nephrology, 11, 23-33. https://doi.org/10.1038/nrneph.2014.202
|
[14]
|
Chung, A.C. and Lan, H.Y. (2015) MicroRNAs in Renal Fibrosis. Frontiers in Physiology, 6, 50. https://doi.org/10.3389/fphys.2015.00050
|
[15]
|
Aguiar, P., Costa, M.C., Azevedo, O., Fiúza, M., Marino, J., Soares, J.L.D. and Enguita, F.J. (2017) MicroRNAs in Fabry Disease: Role as Biomarkers and a Possible Pathophysiological Pathway. Molecular Genetics and Metabolism, 120, S17.
|
[16]
|
Aguiar, P., Azevedo, O., Pinto, R., Marino, J., Cardoso, C., Soares, J.L.D. and Hughes, D. (2017) Increase Synthesis of Collagen Type I: An Early Event in Fabry Cardiomyopathy. New Biomarkers? Molecular Genetics and Metabolism, 120, S17-S18.
|
[17]
|
Pasqualim, G.P.é., Angrezani, J., Giugliani, R., Vairo, F. and Matte, U. (2017) MicroRNA and Gene Expression Studies Provide Novel Information to Understand Heart Disease in Women with Fabry Disease. Molecular Genetics and Metabolism, 120, S106.
|
[18]
|
Cammarata, G., Scalia, S., Colomba, P., Zizzo, C., Pisani, A., Riccio, E., Montalbano, M., Alessandro, R., Giordano, A. and Duro, G. (2018) A Pilot Study of Circulating MicroRNAs as Potential Biomarkers of Fabry Disease. Oncotarget, 9, 27333-27345. https://doi.org/10.18632/oncotarget.25542
|
[19]
|
Hopkin, R.J., Jefferies, J.L., Laney, D.A., Lawson, V.H., Mauer, M., Taylor, M.R., Wilcox, W.R. and Fabry, P. (2016) The Management and Treatment of Children with Fabry Disease: A United States-Based Perspective. Molecular Genetics and Metabolism, 117, 104-113. https://doi.org/10.1016/j.ymgme.2015.10.007
|
[20]
|
Eng, C.M., Resnick-Silverman, L.A., Niehaus, D.J., Astrin, K.H. and Desnick, R.J. (1993) Nature and Frequency of Mutations in the Alpha-Galactosidase A Gene That Cause Fabry Disease. The American Journal of Human Genetics, 53, 1186-1197.
|
[21]
|
Schirinzi, A., Centra, M., Prattichizzo, C., Gigante, M., De Fabritiis, M., Giancaspro, V., Petrarulo, F., Santacroce, R., Margaglione, M., Gesualdo, L. and Ranieri, E. (2008) Identification of GLA Gene Deletions in Fabry Patients by Multiplex Ligation-Dependent Probe Amplification (MLPA). Molecular Genetics and Metabolism, 94, 382-385. https://doi.org/10.1016/j.ymgme.2008.03.017
|
[22]
|
Li, Y., Scott, C.R., Chamoles, N.A., Ghavami, A., Pinto, B.M., Turecek, F. and Gelb, M.H. (2004) Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening. Clinical Chemistry, 50, 1785-1796. https://doi.org/10.1373/clinchem.2004.035907
|
[23]
|
Peralta, C.A., Shlipak, M.G., Judd, S., Cushman, M., McClellan, W., Zakai, N.A., Safford, M.M., Zhang, X., Muntner, P. and Warnock, D. (2011) Detection of Chronic Kidney Disease with Creatinine, Cystatin C, and Urine Albumin-to-Creatinine Ratio and Association with Progression to End-Stage Renal Disease and Mortality. JAMA, 305, 1545-1552. https://doi.org/10.1001/jama.2011.468
|
[24]
|
Tondel, C., Ramaswami, U., Aakre, K.M., Wijburg, F., Bouwman, M. and Svarstad, E. (2010) Monitoring Renal Function in Children with Fabry Disease: Comparisons of Measured and Creatinine-Based Estimated Glomerular Filtration Rate. Nephrology Dialysis Transplantation, 25, 1507-1513. https://doi.org/10.1093/ndt/gfp658
|
[25]
|
Chen, C., Ridzon, D.A., Broomer, A.J., Zhou, Z., Lee, D.H., Nguyen, J.T., Barbisin, M., Xu, N.L., Mahuvakar, V.R., Andersen, M.R., Lao, K.Q., Livak, K.J. and Guegler, K.J. (2005) Real-Time Quantification of microRNAs by Stem-Loop RT-PCR. Nucleic Acids Research, 33, e179.
|
[26]
|
Bustin, S.A., Beaulieu, J.F., Huggett, J., Jaggi, R., Kibenge, F.S., Olsvik, P.A., Penning, L.C. and Toegel, S. (2010) MIQE Precis: Practical Implementation of Minimum Standard Guidelines for Fluorescence-Based Quantitative Real-Time PCR Experiments. BMC Molecular Biology, 11, 74. https://doi.org/10.1186/1471-2199-11-74
|
[27]
|
Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J. and Wittwer, C.T. (2009) The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clinical Chemistry, 55, 611-622. https://doi.org/10.1373/clinchem.2008.112797
|
[28]
|
Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F. and Vandesompele, J. (2009) A Novel and Universal Method for microRNA RT-qPCR Data Normalization. Genome Biology, 10, R64.
|
[29]
|
Livak, K.J. and Schmittgen, T.D. (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta DeltaC(T)) Method. Methods, 25, 402-408. https://doi.org/10.1006/meth.2001.1262
|
[30]
|
Ramaswami, U., Whybra, C., Parini, R., Pintos-Morell, G., Mehta, A., Sunder-Plassmann, G., Widmer, U., Beck, M. and F.O.S.E. Investigators (2006) Clinical Manifestations of Fabry Disease in Children: Data from the Fabry Outcome Survey. Acta Paediatrica, 95, 86-92. https://doi.org/10.1080/08035250500275022
|
[31]
|
Laney, D.A., Peck, D.S., Atherton, A.M., Manwaring, L.P., Christensen, K.M., Shankar, S.P., Grange, D.K., Wilcox, W.R. and Hopkin, R.J. (2015) Fabry Disease in Infancy and Early Childhood: A Systematic Literature Review. Genetics in Medicine, 17, 323-330. https://doi.org/10.1038/gim.2014.120
|
[32]
|
Liguori, R., Di Stasi, V., Bugiardini, E., Mignani, R., Burlina, A., Borsini, W., Baruzzi, A., Montagna, P. and Donadio, V. (2010) Small Fiber Neuropathy in Female Patients with Fabry Disease. Muscle & Nerve, 41, 409-412. https://doi.org/10.1002/mus.21606
|
[33]
|
Biegstraaten, M., Hollak, C.E., Bakkers, M., Faber, C.G., Aerts, J.M. and van Schaik, I.N. (2012) Small Fiber Neuropathy in Fabry Disease. Molecular Genetics and Metabolism, 106, 135-141. https://doi.org/10.1016/j.ymgme.2012.03.010
|
[34]
|
Zar-Kessler, C., Karaa, A., Sims, K.B., Clarke, V. and Kuo, B. (2016) Understanding the Gastrointestinal Manifestations of Fabry Disease: Promoting Prompt Diagnosis. Therapeutic Advances in Gastroenterology, 9, 626-634. https://doi.org/10.1177/1756283X16642936
|
[35]
|
Seydelmann, N., Wanner, C., Stork, S., Ertl, G. and Weidemann, F. (2015) Fabry Disease and the Heart. Best Practice & Research: Clinical Endocrinology & Metabolism, 29, 195-204. https://doi.org/10.1016/j.beem.2014.10.003
|
[36]
|
Tuttolomondo, A., Pecoraro, R., Simonetta, I., Miceli, S., Arnao, V., Licata, G. and Pinto, A. (2013) Neurological Complications of Anderson-Fabry Disease. Current Pharmaceutical Design, 19, 6014-6030. https://doi.org/10.2174/13816128113199990387
|
[37]
|
Schiffmann, R., Warnock, D.G., Banikazemi, M., Bultas, J., Linthorst, G.E., Packman, S., Sorensen, S.A., Wilcox, W.R. and Desnick, R.J. (2009) Fabry Disease: Progression of Nephropathy, and Prevalence of Cardiac and Cerebrovascular Events before Enzyme Replacement Therapy. Nephrology Dialysis Transplantation, 24, 2102-2111. https://doi.org/10.1093/ndt/gfp031
|
[38]
|
Jaurretche, S., Antogiovanni, N. and Perreta, F. (2017) Prevalence of Chronic Kidney Disease in Fabry Disease Patients: Multicenter Cross Sectional Study in Argentina. Molecular Genetics and Metabolism, 12, 41-43. https://doi.org/10.1016/j.ymgmr.2017.05.007
|
[39]
|
Schiffmann, R., Waldek, S., Benigni, A. and Auray-Blais, C. (2010) Biomarkers of Fabry Disease Nephropathy. Clinical Journal of the American Society of Nephrology, 5, 360-364. https://doi.org/10.2215/CJN.06090809
|
[40]
|
Meng, X.M., Tang, P.M., Li, J. and Lan, H.Y. (2015) TGF-Beta/Smad Signaling in Renal Fibrosis. Frontiers in Physiology, 6, 82. https://doi.org/10.3389/fphys.2015.00082
|
[41]
|
Bottinger, E.P. (2007) TGF-Beta in Renal Injury and Disease. Seminars in Nephrology, 27, 309-320. https://doi.org/10.1016/j.semnephrol.2007.02.009
|
[42]
|
Bartel, D.P. (2018) Metazoan MicroRNAs. Cell, 173, 20-51. https://doi.org/10.1016/j.cell.2018.03.006
|